Oculis will not pursue FDA approval for OCS-01, an eye drop for diabetic macular edema, after it failed to meet the primary ...

Ollin Biosciences, Inc. (Ollin), a clinical-stage biotech advancing best-in-disease therapies for vision-threatening diseases ...

Oculis Holding AG OCS stock is down on Monday after the company announced disappointing results from its Phase 3 DIAMOND ...

Oculis Holding AG shares plunged >35% after both Phase 3 DIAMOND trials for OCS-01 in diabetic macular edema failed primary ...

OCS-01 failed to meet the primary endpoint of improving visual acuity in both Phase 3 DIAMOND studies. ・The treatment reduced ...

Diabetic macular edema (DME) is an eye condition that can lead to vision loss in people with diabetes. It occurs as a result of diabetic retinopathy — damaged blood vessels in the eyes due to elevated ...

What are the early signs of diabetic macular edema? Early signs you may have diabetic macular edema include blurred vision, colors appearing faded or dull, and distorted vision where objects look wavy ...

Diabetic macular edema (DME) occurs when fluid accumulates in the retina due to high blood sugar damaging blood vessels. Research suggests the same vascular damage that causes DME also increases your ...

Diabetic macular edema (DME) is a diabetes complication that can cause low vision or vision loss. Early treatment may help preserve vision longer. High blood sugar can damage tiny eye blood vessels, ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

Vision tools, rehabilitation, and lifestyle changes can all help improve the experience of living with diabetic macular edema (DME). Macular edema is a condition that involves swelling in the eye that ...